Health Canada Grants Authorization for Leqembi® (lecanemab)
Go back to Health Canada Grants Authorization for Leqembi® (lecanemab)| BARNES GROUP, Inc. (NYSE: B) | Delayed: 37.11 -0.05 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.16 | 52 Week High | $44.27 | |||
| Open | $37.45 | 52 Week Low | $30.07 | |||
| Day High | $37.71 | P/E | 28.33 | |||
| Day Low | $36.93 | EPS | $1.31 | |||
| Volume | 5,380,714 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 21.77 -0.13 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.90 | 52 Week High | $8.73 | |||
| Open | $21.90 | 52 Week Low | $2.86 | |||
| Day High | $22.32 | P/E | N/A | |||
| Day Low | $21.35 | EPS | $-3.82 | |||
| Volume | 1,031,115 | |||||
